Thoracentesis And Paracentesis Market Report 2026

Thoracentesis And Paracentesis Market Overview

• Thoracentesis And Paracentesis market size has reached to $1.49 billion in 2025 • Expected to grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Rising Prevalence Of Chronic Diseases Fueling The Growth Of The Market Due To Increasing Patient Burden • Market Trend: Ergonomic Design Enhancements Improve Healthcare Professional Usability And Efficiency • Asia-Pacific was the largest region and fastest growing region.

What Is Covered Under Thoracentesis And Paracentesis Market?

Thoracentesis and paracentesis are medical procedures used to remove excess fluid from the pleural and peritoneal cavities, respectively. These procedures help relieve symptoms such as shortness of breath and abdominal discomfort caused by fluid accumulation. They are performed using specialized needles and catheter systems to ensure safe and effective fluid drainage. The main procedure types of thoracentesis and paracentesis include ultrasound-guided and blind or conventional procedures. Ultrasound-guided thoracentesis and paracentesis are procedures that use ultrasound imaging to safely remove fluid from the pleural or abdominal cavity for diagnostic or therapeutic purposes. The various product types include thoracentesis kits, paracentesis kits, and other product types and are indicated for conditions such as ascites, pleural effusion, empyema, and hemothorax. They find application in diagnostic and therapeutic procedures, serving end users including hospitals, clinics, ambulatory surgical centers, and other end users.

What Is The Thoracentesis And Paracentesis Market Growth Forecast?

The thoracentesis and paracentesis market size is expected to see strong growth in the next few years. It will grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growth in ultrasound-guided procedure adoption, development of advanced thoracentesis and paracentesis kits, integration with digital procedural management, expansion of ambulatory surgical centers, investment in patient safety and procedural efficiency. Major trends in the forecast period include ultrasound-guided procedure adoption, minimally invasive techniques, point-of-care fluid drainage, enhanced procedural safety measures, procedure-specific therapeutic kits.

Global Thoracentesis And Paracentesis Market Segmentation

1) By Procedure Type: Ultrasound-Guided Procedures, Blind Or Conventional Procedures 2) By Product Type: Thoracentesis Kits, Paracentesis Kits, Other Product Types 3) By Indication: Ascites, Pleural Effusion, Empyema, Hemothorax 4) By Application: Diagnostic, Therapeutic 5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Ultrasound-Guided Procedures: Diagnostic Ultrasound Guided Procedure, Therapeutic Ultrasound Guided Procedure, Emergency Ultrasound Guided Procedure 2) By Blind Or Conventional Procedures: Diagnostic Blind Procedure, Therapeutic Blind Procedure, Emergency Blind Procedure

What Are The Drivers Of The Thoracentesis And Paracentesis Market?

The rising prevalence of chronic diseases is expected to propel the growth of the thoracentesis and paracentesis market going forward. Chronic diseases are long-lasting medical conditions that persist for months or years, often progress slowly, and typically require ongoing management rather than a complete cure. The rise in prevalence of chronic diseases is partly due to inactive lifestyles, as prolonged sitting and minimal physical activity raise the risk of diseases such as heart conditions and diabetes. Thoracentesis and paracentesis support chronic disease management by providing minimally invasive procedures to remove excess fluid from the pleural or abdominal cavities, alleviating symptoms and improving patient comfort. They enable timely monitoring and intervention for conditions such as heart failure, liver disease, and malignancies, reducing complications and enhancing overall disease management and quality of life. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, approximately 76.4% of U.S. adults (194 million) had at least one chronic condition, with 51.4% (131 million) experiencing multiple chronic conditions. Therefore, the rising prevalence of chronic diseases is driving the growth of the thoracentesis and paracentesis industry. The rising healthcare spending is expected to propel the growth of the thoracentesis and paracentesis market going forward. Healthcare spending is the total amount of money spent on medical services, products, and public health activities to prevent, diagnose, treat, and manage illnesses and maintain overall health. The increasing demand for healthcare expenditure is due to the rising prevalence of chronic diseases, which require long-term and costly treatments. Thoracentesis and paracentesis help reduce healthcare spending by enabling minimally invasive fluid removal, which decreases hospital stays, lowers complication rates, and reduces the need for costly interventions. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, an increase of 0.9% growth compared to 2022. Therefore, rising healthcare spending is driving the growth of the thoracentesis and paracentesis industry.

Key Players In The Global Thoracentesis And Paracentesis Market

Major companies operating in the thoracentesis paracentesis market are Cardinal Health Inc., Medtronic plc, Becton Dickinson Company, Boston Scientific Corporation, Teleflex Incorporated, Cook Medical LLC, Merit Medical Systems Inc., Redax S.p.A., Avanos Medical Inc., Poly Medicure Ltd., Axiom Medical Inc., Angiplast Private Limited, Utah Medical Products Inc., Mermaid Medical A/S, PFM Medical AG, ITL Australia Pty Ltd, ATMOS MedizinTechnik GmbH & Co. KG, Vygon SA, PolyMed Medical Devices Pvt. Ltd., Sterimed Medical Devices Pvt. Ltd., Blue Neem Medical Devices Pvt. Ltd.

Global Thoracentesis And Paracentesis Market Trends and Insights

Major companies operating in the thoracentesis and paracentesis market are focusing on developing technologically advanced solutions, such as fluid drainage automation, to enhance procedural safety, reduce patient discomfort, improve clinical efficiency, and enable real-time monitoring for better treatment outcomes. Fluid drainage automation is the use of devices or systems to automatically control the removal of bodily fluids from cavities, regulating flow, pressure, and safety to improve efficiency and patient comfort. For instance, in January 2024, Laborie Medical Technologies Inc., a US-based medical technology company, introduced the RenovarP Centesis System. It is a fluid drainage device that builds upon an existing paracentesis pump by adding an expanded indication for thoracentesis. It includes design enhancements to the handle and nest, improving the overall user experience for healthcare professionals. It offers a safe, efficient, and minimally invasive solution for draining fluid from the abdomen (paracentesis) and chest (thoracentesis), aiming to improve patient comfort and reduce recovery times.

Regional Insights

North America was the largest region in the thoracentesis and paracentesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Thoracentesis And Paracentesis Market?

The thoracentesis and paracentesis market includes revenues earned by entities through procedure assistance, device maintenance, clinical training, hospital implementation, technical support, patient monitoring, post procedure care, and healthcare consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Thoracentesis And Paracentesis Market Report 2026?

The thoracentesis and paracentesis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the thoracentesis and paracentesis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.